150 related articles for article (PubMed ID: 19802419)
41. Clinical isolates of Mycobacterium abscessus in Guangzhou area most possibly from the environmental infection showed variable susceptibility.
Zhuo FL; Sun ZG; Li CY; Liu ZH; Cai L; Zhou C; Zhang JZ
Chin Med J (Engl); 2013; 126(10):1878-83. PubMed ID: 23673103
[TBL] [Abstract][Full Text] [Related]
42. [In vitro sensitivity of Mycobacterium chelonae strains to various antimicrobial agents].
Hernández García AM; Arias A; Felipe A; Alvarez R; Sierra A
Microbiologia; 1995 Dec; 11(4):485-90. PubMed ID: 8588844
[TBL] [Abstract][Full Text] [Related]
43. In vitro drug susceptibility of Mycobacterium other than tubercle bacilli.
Imwidthaya P; Komolpis P; Suthiravitayavaniz K; Rienthong S
J Med Assoc Thai; 1990 Aug; 73(8):438-42. PubMed ID: 2262746
[TBL] [Abstract][Full Text] [Related]
44. In vitro drug susceptibility of 40 international reference rapidly growing mycobacteria to 20 antimicrobial agents.
Pang H; Li G; Wan L; Jiang Y; Liu H; Zhao X; Zhao Z; Wan K
Int J Clin Exp Med; 2015; 8(9):15423-31. PubMed ID: 26629031
[TBL] [Abstract][Full Text] [Related]
45. Mycobacterium massiliense is differentiated from Mycobacterium abscessus and Mycobacterium bolletii by erythromycin ribosome methyltransferase gene (erm) and clarithromycin susceptibility patterns.
Kim HY; Kim BJ; Kook Y; Yun YJ; Shin JH; Kim BJ; Kook YH
Microbiol Immunol; 2010 Jun; 54(6):347-53. PubMed ID: 20536733
[TBL] [Abstract][Full Text] [Related]
46. Prevalence of erm methylase genes in clinical isolates of non-pigmented, rapidly growing mycobacteria.
Esteban J; Martín-de-Hijas NZ; García-Almeida D; Bodas-Sánchez A; Gadea I; Fernández-Roblas R
Clin Microbiol Infect; 2009 Oct; 15(10):919-23. PubMed ID: 19438639
[TBL] [Abstract][Full Text] [Related]
47. Nationwide surveillance of antimicrobial susceptibility of 509 rapidly growing mycobacteria strains isolated from clinical specimens in Japan.
Kamada K; Yoshida A; Iguchi S; Arai Y; Uzawa Y; Konno S; Shimojima M; Kikuchi K
Sci Rep; 2021 Jun; 11(1):12208. PubMed ID: 34108590
[TBL] [Abstract][Full Text] [Related]
48. Screening for sterilizing activity of antibiotic combinations in an acid model of rapidly growing mycobacteria during the stationary phase of growth.
Cremades R; Santos A; Rodríguez JC; García-Pachón E; Ruiz M; Escribano I; Royo G
Chemotherapy; 2009; 55(2):114-8. PubMed ID: 19155619
[TBL] [Abstract][Full Text] [Related]
49. Molecular identification of rapidly growing mycobacteria isolates from pulmonary specimens of patients in the State of Pará, Amazon region, Brazil.
da Costa AR; Lopes ML; Leão SC; Schneider MP; de Sousa MS; Suffys PN; Corvelo TC; Lima KV
Diagn Microbiol Infect Dis; 2009 Dec; 65(4):358-64. PubMed ID: 19796904
[TBL] [Abstract][Full Text] [Related]
50. In vitro drug susceptibility of 2275 clinical non-tuberculous Mycobacterium isolates of 49 species in The Netherlands.
van Ingen J; van der Laan T; Dekhuijzen R; Boeree M; van Soolingen D
Int J Antimicrob Agents; 2010 Feb; 35(2):169-73. PubMed ID: 20006470
[TBL] [Abstract][Full Text] [Related]
51. Mupirocin resistance among Iranian isolates of Staphylococcus aureus.
Saderi H; Owlia P; Habibi M
Med Sci Monit; 2008 Oct; 14(10):BR210-3. PubMed ID: 18830185
[TBL] [Abstract][Full Text] [Related]
52. Determination of antimicrobial susceptibility patterns of Nocardia spp. from clinical specimens by Etest.
Glupczynski Y; Berhin C; Janssens M; Wauters G
Clin Microbiol Infect; 2006 Sep; 12(9):905-12. PubMed ID: 16882297
[TBL] [Abstract][Full Text] [Related]
53. Nontuberculous mycobacterial infections of the skin: A retrospective study of 25 cases.
Dodiuk-Gad R; Dyachenko P; Ziv M; Shani-Adir A; Oren Y; Mendelovici S; Shafer J; Chazan B; Raz R; Keness Y; Rozenman D
J Am Acad Dermatol; 2007 Sep; 57(3):413-20. PubMed ID: 17368631
[TBL] [Abstract][Full Text] [Related]
54. Nontuberculous mycobacterial skin infections: clinical and bacteriological studies.
Mahaisavariya P; Chaiprasert A; Khemngern S; Manonukul J; Gengviniij N; Ubol PN; Pinitugsorn S
J Med Assoc Thai; 2003 Jan; 86(1):52-60. PubMed ID: 12678139
[TBL] [Abstract][Full Text] [Related]
55. Epidemiology of Rapidly Growing Mycobacteria Bloodstream Infections.
Rodriguez-Coste MA; Chirca I; Steed LL; Salgado CD
Am J Med Sci; 2016 Mar; 351(3):253-8. PubMed ID: 26992253
[TBL] [Abstract][Full Text] [Related]
56. Catheter-related bloodstream infections caused by rapidly growing nontuberculous mycobacteria: a case series including rare species.
Hawkins C; Qi C; Warren J; Stosor V
Diagn Microbiol Infect Dis; 2008 Jun; 61(2):187-91. PubMed ID: 18294801
[TBL] [Abstract][Full Text] [Related]
57. In vitro susceptibility of Mycobacterium fortuitum, Mycobacterium chelonae and Mycobacterium avium against some quinolones.
Casal M; Rodriguez F; Villalba R; Benavente MC; Gonzalez AI
Chemioterapia; 1987 Dec; 6(6):431-3. PubMed ID: 3481302
[TBL] [Abstract][Full Text] [Related]
58. Evaluation of Etest for rapid susceptibility testing of Mycobacterium chelonae and M. fortuitum.
Hoffner SE; Klintz L; Olsson-Liljequist B; Bolmström A
J Clin Microbiol; 1994 Aug; 32(8):1846-9. PubMed ID: 7989530
[TBL] [Abstract][Full Text] [Related]
59. Antibiotic Susceptibility of Mycobacteria Isolated from Ornamental Fish.
Guz L; Puk K
J Vet Res; 2022 Mar; 66(1):69-76. PubMed ID: 35582485
[TBL] [Abstract][Full Text] [Related]
60. Rapid Mycobacterium abscessus antimicrobial susceptibility testing based on antibiotic treatment response mapping via Raman Microspectroscopy.
Ren W; Mao Y; Li S; Gao B; Fu X; Liu X; Zhu P; Shang Y; Li Y; Ma B; Sun L; Xu J; Pang Y
Ann Clin Microbiol Antimicrob; 2023 Oct; 22(1):94. PubMed ID: 37904155
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
